|
New product release - LiDCOview Pro
26 February 2008
LiDCO, the UK based, AIM-quoted cardiovascular monitoring company, today
announces the launch of its new data viewing and analysis software product
LiDCOview Pro.
LiDCOview Pro has been developed as a PC based complementary software tool for
LiDCOplus Monitor users. LiDCOview Pro software is designed to display
historical hemodynamic data recorded by the LiDCOplus monitor. Clinical
research, auditing, training and information sharing are all enhanced by the
ability to rapidly convert beat-to-beat data into visual displays and reports.
LiDCOview Pro can display up to 24 hours at a time of hemodynamic data and has
built in navigation tools to make finding data of interest very easy. The
software also has, for the first time ever, a display of fluid responsiveness
parameters showing relevant trends. Analysis and reporting of the data can be
made to generate hourly observation reports. Likewise, audits of the data to
determine if specific targets have been met, can be generated. LiDCO expect one
of its main uses will be to audit the success of early goal directed therapy,
through use of the LiDCOplus Monitor, which has been shown to dramatically
reduce complications and length of stay.
Terry O'Brien, CEO of LiDCO commented: 'LiDCOview Pro is a valuable addition to
the growing LiDCO product family. Complex data can now be analysed and the
achievement of therapeutic goals assessed by all staff with access to an
ordinary computer and our software. '
| For more information please contact: |
|
|
| |
|
|
| LiDCO Group Plc |
|
Tel: +44 (0)20 7749 1500 |
Terry O'Brien - Chief Executive
Theresa Wallis - Non-Executive Chairman |
|
|
| |
|
|
| Buchanan Communications |
|
Tel: +44 (0)20 7466 5000 |
| Tim Anderson, James Strong |
|
|
Notes for Editors
About LiDCO Group Plc
LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of
minimally invasive, computer-based hemodynamic monitoring equipment and
disposables used primarily for the management of critical care and
cardiovascular risk hospital patients. Use of LiDCO's technology has been shown
to significantly reduce the complications (particularly infections) and costs
associated with major surgery. The technology was invented in the Department of
Applied Physiology based at St Thomas' Hospital, London. For more information
please see www.lidco.com.
The Company's manufacturing facility is in Hoxton, London and its current
products are:
- LiDCOplus and PulseCO monitors: computer-based platforms for displaying a
range of real-time, continuous hemodynamic parameters including cardiac output,
oxygen delivery and fluid volume (PPV and SVV).
- LiDCO disposables: used in conjunction with the LiDCOplus Monitor to
accurately determine cardiac output in a minimally-invasive manner.
- LiDCOview - software product for use on a PC: designed to aid clinical audit,
teaching and research activities.
- LiDCOlive - software product in development for the remote display of
hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.
Distribution Network:
The Company has now achieved registration of its products in 14 markets in
Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and
USA, and elsewhere through a worldwide network of speciality critical care and
anesthesia distributors.
|